These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37378945)

  • 1. Topoisomerase IIalpha (TopoIIa) A New Promising Marker for Early Detection of Laryngeal Squamous Cell Carcinoma: An Immunohistochemical Study.
    Salama MEM; Yaqout MAT; Habib FM; Abdel-Salam SM
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):2135-2139. PubMed ID: 37378945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of topoisomerase IIa expression in pancreatic ductal adenocarcinoma: a pilot study using chromogenic in situ hybridization and immunohistochemistry on tissue microarrays.
    Tsiambas E; Karameris A; Tiniakos DG; Karakitsos P
    Pancreatology; 2007; 7(1):45-52. PubMed ID: 17449965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.
    Kucukgoz Gulec U; Gumurdulu D; Guzel AB; Paydas S; Seydaoglu G; Acikalin A; Khatib G; Zeren H; Vardar MA; Altintas A
    Arch Gynecol Obstet; 2014 Feb; 289(2):393-8. PubMed ID: 23974278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
    Brustmann H; Naudé S
    Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
    Mattila R; Alanen K; Syrjänen S
    Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of topoisomerase II alpha and Her-2/neu in prostatic carcinoma and benign prostatic hyperplasia.
    Hasby EA; Saied EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):158-67. PubMed ID: 20029472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase II alpha expression in breast ductal invasive carcinomas and correlation with clinicopathological variables.
    Kalogeraki A; Ieromonachou P; Kafousi M; Giannikaki E; Vrekoussis T; Zoras O; Tsiftsis D; Delides G; Stathopoulos E
    In Vivo; 2005; 19(5):837-40. PubMed ID: 16097435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer.
    Nakopoulou L; Lazaris AC; Kavantzas N; Alexandrou P; Athanassiadou P; Keramopoulos A; Davaris P
    Pathobiology; 2000; 68(3):137-43. PubMed ID: 11174071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.
    Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M
    Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase I deregulation in laryngeal squamous cell carcinomas based on tissue microarray analysis.
    Papadas TA; Tsiambas E; Mastronikolis NS; Karameris A; Mastronikolis SN; Papadas AT; Fotiades PP; Ragos V
    J BUON; 2017; 22(3):771-776. PubMed ID: 28730788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase IIa protein expression analysis in oral squamous cell carcinoma.
    Papanikolaou V; Kyrodimos E; Mastronikolis N; Tsiambas E; Ragos V; Chrysovergis A
    J BUON; 2021; 26(3):769-773. PubMed ID: 34268934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining for DNA topoisomerase IIa in Hodgkin's disease.
    Brown MS; Holden JA; Rahn MP; Perkins SL
    Am J Clin Pathol; 1998 Jan; 109(1):39-44. PubMed ID: 9426516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas.
    Hafian H; Venteo L; Sukhanova A; Nabiev I; Lefevre B; Pluot M
    Hum Pathol; 2004 Jun; 35(6):745-51. PubMed ID: 15188142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity.
    Berney DM; Stankiewicz E; Adlan AM; Kudahetti S; Biedrzycki OJ; Hadway P; Watkin N; Corbishley C
    BJU Int; 2008 Sep; 102(8):1040-4. PubMed ID: 18489530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy.
    Tsavaris N; Lazaris A; Kosmas C; Gouveris P; Kavantzas N; Kopterides P; Papathomas T; Agrogiannis G; Zorzos H; Kyriakou V; Patsouris E
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):391-8. PubMed ID: 19083133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
    Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K
    Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis.
    Manaios L; Tsiambas E; Alevizaki M; Karameris A; Alexopoulou D; Lambropoulou S; Moreas H; Kravvaritis C; Fotiades PP; Goula K; Patsouris E; Athanassiou AE; Koutras D; Katsilambros N
    J BUON; 2008; 13(4):537-41. PubMed ID: 19145676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.